D. Holder

Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor

J. Mellors, J. Condra, W. Schleif, 1996, Journal of virology.

The Relation between Baseline HIV Drug Resistance and Response to Antiretroviral Therapy: Re-Analysis of Retrospective and Prospective Studies Using a Standardized Data Analysis Plan

S. Hammer, S. Yerly, A. Zolopa, 2000, Antiviral therapy.

Simultaneous vs sequential initiation of therapy with indinavir, zidovudine, and lamivudine for HIV-1 infection: 100-week follow-up.

D. Richman, D. Havlir, J. Mellors, 1998, JAMA.

Letermovir Resistance Analysis in a Clinical Trial of Cytomegalovirus Prophylaxis for Hematopoietic Stem Cell Transplant Recipients.

D. Nickle, L. van Doorn, D. Holder, 2019, The Journal of infectious diseases.

Impact of glycoprotein B genotype and naturally occurring ORF UL56 polymorphisms upon susceptibility of clinical human cytomegalovirus isolates to letermovir.

D. Holder, Douglas Zhang, H. Zimmermann, 2016, Antiviral research.

Intact Human Immunodeficiency Virus (HIV) Reservoir Estimated by the Intact Proviral DNA Assay Correlates With Levels of Total and Integrated DNA in the Blood During Suppressive Antiretroviral Therapy.

D. Richman, L. Montaner, E. Papasavvas, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Efficacy of indinavir–ritonavir-based regimens in HIV-1-infected patients with prior protease inhibitor failures

Jennifer L. Wright, J. Condra, W. Schleif, 2003, AIDS.

Factors influencing the emergence of resistance to indinavir: role of virologic, immunologic, and pharmacologic variables.

J. Bilello, J. Condra, P. Deutsch, 1998, The Journal of infectious diseases.

Intact HIV reservoir estimated by the intact proviral DNA assay correlates with levels of total and integrated DNA in the blood during suppressive antiretroviral therapy.

D. Richman, L. Montaner, E. Papasavvas, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.